Oral absorption and in vivo biodistribution of α-conotoxin MII and a lipidic analogue
- 11 July 2007
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 361 (1) , 97-102
- https://doi.org/10.1016/j.bbrc.2007.06.138
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Therapeutic applications of conotoxins that target the neuronal nicotinic acetylcholine receptorToxicon, 2006
- Engineering stable peptide toxins by means of backbone cyclization: Stabilization of the α-conotoxin MIIProceedings of the National Academy of Sciences, 2005
- α-Conotoxins as selective probes for nicotinic acetylcholine receptor subclassesCurrent Opinion in Pharmacology, 2005
- Ziconotide: Neuronal Calcium Channel Blocker for Treating Severe Chronic PainCurrent Medicinal Chemistry, 2004
- Drugs from the Sea: Conopeptides as Potential TherapeuticsCurrent Medicinal Chemistry, 2004
- Conus Peptides Targeted to Specific Nicotinic Acetylcholine Receptor SubtypesAnnual Review of Biochemistry, 1999
- Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calciumJournal of Neuroscience, 1993
- Methyllycaconitine: a selective probe for neuronal α‐bungarotoxin binding sitesFEBS Letters, 1990
- Neurotoxins Distinguish Between Different Neuronal Nicotinic Acetylcholine Receptor Subunit CombinationsJournal of Neurochemistry, 1990
- Diversity of Conus NeuropeptidesScience, 1990